A detailed history of Bank Of America Corp transactions in Mannkind Corp stock. As of the latest transaction made, Bank Of America Corp holds 1,240,509 shares of MNKD stock, worth $8.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,240,509
Previous 2,422,279 48.79%
Holding current value
$8.14 Million
Previous $11 Million 40.99%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.05 - $5.43 $4.79 Million - $6.42 Million
-1,181,770 Reduced 48.79%
1,240,509 $6.48 Million
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $5.55 Million - $9 Million
1,706,980 Added 238.64%
2,422,279 $11 Million
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $424,971 - $545,846
-127,237 Reduced 15.1%
715,299 $2.6 Million
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $7.42 Million - $9.56 Million
-1,995,567 Reduced 70.31%
842,536 $3.43 Million
Q1 2023

May 12, 2023

BUY
$3.95 - $5.63 $5.83 Million - $8.31 Million
1,475,480 Added 108.28%
2,838,103 $11.6 Million
Q4 2022

Feb 10, 2023

BUY
$3.02 - $5.37 $1.41 Million - $2.51 Million
467,576 Added 52.24%
1,362,623 $7.18 Million
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $1.69 Million - $2.46 Million
565,293 Added 171.43%
895,047 $2.77 Million
Q2 2022

Aug 12, 2022

SELL
$2.67 - $4.77 $3.48 Million - $6.21 Million
-1,302,448 Reduced 79.8%
329,754 $1.26 Million
Q1 2022

May 16, 2022

BUY
$2.62 - $4.45 $1.51 Million - $2.56 Million
576,320 Added 54.58%
1,632,202 $6.01 Million
Q4 2021

Feb 08, 2022

BUY
$4.05 - $5.37 $2.59 Million - $3.44 Million
640,599 Added 154.26%
1,055,882 $4.61 Million
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $192,263 - $270,849
49,425 Added 13.51%
415,283 $1.81 Million
Q2 2021

Sep 13, 2021

BUY
$3.61 - $5.45 $1.32 Million - $1.99 Million
365,858 New
365,858 $1.99 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.69B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.